Nature CommunicationsImmunologyPeer-reviewed journal article
The immune profile of circulating autoreactive CD4 T cells is imprinted through tissue activation during autoimmune liver diseases
Anaïs CardoniD, Thomas GuinebretièreiD, Chuang DongiD, Laurine Gil, Sakina Ado, Pierre-Jean GavlovskyiD, Martin BraudiD, Richard DangeriD, Christoph SchultheißiD, Aurélie DoménéiD, Perrine Paul‐GilloteauxiD, Caroline ChevalieriD, Laura Bernier, Jean‐Paul Judor, Cynthia FourgeuxiD, Astrid Imbert, Marion Khaldi, Edouard Bardou‐JacquetiD, Laure ElkriefiD, Adrien Lannes, Christine SilvainiD, Matthieu SchneeiD, Florence Tanné, Fabienne VavasseuriD, Lucas Brusselle, , Amédée RenandiD
Abstract
Autoimmune liver diseases (AILD) are immune-mediated disorders in which CD4 T cells play a central role. However, the link between circulating self-antigen-specific CD4 T cells and the targeted tissue has not been extensively studied in AILD. We hypothesized that circulating autoreactive CD4 T cells were clonally and functionally related to dominant intra-hepatic pathogenic CD4 T cell clones. Single cell transcriptomic analysis of circulating self-antigen-specific CD4 T cells revealed a specific B-helper and immuno-exhausted transcriptional profile, which was conserved for different autoantigens, but distinct from several other types of foreign antigen specificities. In the blood, the dominant hepatic CD4 T cell clones had a similar transcriptomic signature and were enriched in the PD-1+ TIGIT+ HLA-DR+ CD4 T cell subset. In a mouse model, antigen-specific CD4 T cells acquired the immuno-exhausted transcriptional profile when they accumulated in the liver after local antigen reactivity. Locally, immune checkpoint molecules controlled the response of antigen-specific CD4 T cells responsible for liver damage. Our study reveals the origin and biology of liver-derived autoreactive CD4 T cells in the blood of AILD patients that are imprinted by the liver environment, and suggest a dysregulation of the immune checkpoint molecules pathways. Our study enables tracking and isolating circulating autoreactive CD4 T cells for future diagnostic and therapeutic purposes.
- Citations
- 26
- FWCI
- 9.11
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Integrative molecular profiling of autoreactive CD4 T cells in autoimmune hepatitis
A. Renaud, I. Cervera-Marzal, … S. Conchon·Journal of HepatologyPeer-reviewed·Dec 1, 2020
- Preclinical model for the study of immune responses specific for a hepatic self-antigen
A. Cardon, J.-P. Judor, … A. Renand·bioRxiv·Jun 22, 2022
- Macrophage-derived IL-27 sustains autoreactive CD8+ cytotoxic T cells in autoimmune hepatitis
Kaiyuan Hao, Sofia Grace Baptista, … Siva Karthik Varanasi·bioRxiv·Sep 28, 2026
- Accumulation of PD-1+ TIGIT+ T cells in the liver after local antigen reactivity and during autoimmune hepatitis
Thomas Guinebretière, Anaïs Cardon, … Amédée Renand·bioRxiv·Aug 29, 2025
- Imaging guided single-cell multiomics unveils shared autoreactive CD4+ T-cell responses in blood, locoregional lymph node and affected tissues of patients with systemic autoimmunity
Theodoros Ioannis Papadimitriou, Prashant Singh, … Rogier M. Thurlings·bioRxiv·Aug 23, 2026
- Single-cell transcriptome landscape of circulating CD4+ T cell populations in human autoimmune diseases
Y. Yasumizu, D. Takeuchi, … S. Sakaguchi·bioRxiv·May 9, 2023